Injecto Capta Private Limited - Due diligence report

A 360° intelligence report on Injecto Capta: trust score, financial health, credit view, compliance, directors, growth and distress signals …

1992-03-20 Hyderabad, Telangana Amalgamated Unlisted Active Compliant
Share
IC Injecto Capta Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Injecto Capta — 360° Intelligence Report

Generated from MCA filings & public records
64/100
Trust Score
Moderate

Injecto Capta is assessed as Moderate with a Trust Score of 64/100. Injecto Capta is a private limited indian non-government company incorporated in 1992, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Injecto Capta Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 2 satisfied (37.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India2 48.0 cr
Compliance Score: 30/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2019 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SUNIL GULATI 01234567 Director 01/04/2018 6 yrs Approved
DIVITA GULATI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 30
Growth signals & trust indicators
Operating for 34+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence40/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment71/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
08 Jun 2020
Charge satisfied
State Bank Of India
19 Aug 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
02 Mar 2013
Director ceased
SHASHI BALA JAIN
29 Sep 2012
Director ceased
SUNIL GULATI
Director ceased
DIVITA GULATI
08 Aug 2012
Director appointed
SUNIL GULATI (Director)
26 May 2012
Director appointed
DIVITA GULATI (Director)
Director ceased
SURESHKUMAR JAIN
09 Jun 1995
Charge created
State Bank Of India - 22.00 Lakh
03 Oct 1992
Charge created
State Bank Of India - 15.00 Lakh
20 Mar 1992
Incorporated
Registered with Roc Hyderabad
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Balaji Pipe Industries Private Limited U74899DL1983PTC013989 Delhi, Delhi, India
Ritisha Fragrances Private Limited U16009UP2007PTC033645 Mathura, Uttar Pradesh, India
Prolife Fine And Specialty Chemicals Private Limited U45201GJ2011PTC066750 Ahmedabad, Gujarat, India
Iona Pharmatech Private Limited U74120TG2015PTC102307 Hyderabad, Telangana, India
Exhar Formulations Private Limited U51511DL2007PTC162025 New Delhi, Delhi, India
Tejasri Polymers Private Limited U74999AP2008PTC059084 Bhimaram, Andhra Pradesh, India
Zyduscadila U24100GJ2013PLC077080 Vadodara, Gujarat, India
C And C Organics Private Limited U24239DL2004PTC130797 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Injecto Capta before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Injecto Capta: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Injecto Capta - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Injecto Capta pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Injecto Capta - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Injecto Capta an active company?

Injecto Capta has MCA status “Amalgamated” with a compliance score of 30/100 (Caution Indicated).

Is Injecto Capta financially healthy?

Injecto Capta has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Injecto Capta?

Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Injecto Capta?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Injecto Capta have loans or charges against its assets?

No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Injecto Capta up to date with its ROC filings?

Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Injecto Capta?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.